# Anidulafungin Pharmacokinetics in Intensive Care Unit Patients

> **NCT01438216** · — · UNKNOWN · sponsor: **Amsterdam UMC, location VUmc** · enrollment: 20 (estimated)

## Conditions studied

- Invasive Candidiasis
- Candidemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01438216
- **Lead sponsor:** Amsterdam UMC, location VUmc
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-09
- **Primary completion:** 2012-02
- **Final completion:** 2012-03
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2011-09-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01438216

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01438216, "Anidulafungin Pharmacokinetics in Intensive Care Unit Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01438216. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*